Pennsylvania Legislators Propose Marnie’s Law
The proposed legislation mandates medical provider education on inflammatory breast cancer symptoms to improve diagnosis.
Updated on Oct. 20, 2026 in Cancer
Live Poll
Should states mandate specific training for medical providers to identify rare breast cancer types?
Introduced in September 2026, Marnie’s Law aims to reduce diagnostic errors by requiring Pennsylvania healthcare providers to learn about inflammatory breast cancer. The bill is named after Marnie Schulenburg, who died from the disease at age 37 after an initial misdiagnosis of mastitis.
Why it matters
Inflammatory breast cancer often presents without a distinct lump, leading to frequent misdiagnoses that can delay life-saving treatment. This legislation seeks to ensure medical professionals recognize symptoms earlier to improve survival rates.
Inflammatory breast cancer accounts for 1% to 5% of all breast cancer cases. In Pennsylvania, projections indicate more than 250 people could be diagnosed with the condition in 2026, with 700 potential new cases anticipated annually.
The players
Marnie Schulenburg
She was an actress and alumna of DeSales University who died at age 37 from inflammatory breast cancer.
The details
The proposed law requires providers to include instructions to rule out inflammatory breast cancer in patient charts when symptoms like skin changes or breast swelling occur. It follows the case of Marnie Schulenburg, who was misdiagnosed as having mastitis prior to her 2022 death.
Timeline
Marnie Schulenburg died of inflammatory breast cancer in 2022.
Marnie's Law was introduced in the Pennsylvania legislature in September 2026.
Estimates for breast cancer diagnoses and deaths in Pennsylvania are provided for the 2026 calendar year.
Health Landscape
This legislation represents a targeted policy effort to close gaps in clinical awareness that persist despite established National Comprehensive Cancer Network breast cancer screening guidelines. It marks a shift toward state-mandated education to improve detection of aggressive, rare breast cancer subtypes.
For residents experiencing unexplained breast swelling or skin changes, this law aims to ensure medical providers more quickly rule out inflammatory breast cancer. Patients are encouraged to advocate for further testing if initial treatments for suspected mastitis do not resolve symptoms.
The takeaway
Early detection remains the most critical factor in treating aggressive breast cancers that do not present as traditional lumps. Residents should remain vigilant about persistent breast changes and discuss inflammatory breast cancer specifically with their healthcare providers.
Further reading
Learn more about advancements in Cancer treatment and prevention resources.
Live Poll
Should states mandate specific training for medical providers to identify rare breast cancer types?
